Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tackling hyperglycemia: a more comprehensive approach.

Stefano Del Prato1

  • 1Department of Endocrinology and Metabolism, Section of Diabetes, School of Medicine, University of Pisa, Italy.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|April 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial.

Diabetes, obesity & metabolism·2026
Same author

Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial.

Annals of internal medicine·2026
Same author

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

The lancet. Diabetes & endocrinology·2026
Same author

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Cardiovascular diabetology·2026
Same author

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Diabetes care·2026
Same author

Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?

Diabetes, obesity & metabolism·2026

Strict glycemic control, monitored by Hemoglobin A1c, significantly reduces diabetes mortality and complications. Managing both fasting and postprandial glucose is crucial for preventing cardiovascular disease and other diabetes-related issues.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Cardiovascular Health

Background:

  • Diabetes mellitus is characterized by complex metabolic alterations.
  • Glycemic control is a cornerstone in managing diabetes and preventing complications.

Purpose of the Study:

  • To review the key components of glycemic control in diabetic patients.
  • To discuss factors contributing to the development of diabetes-related complications.

Main Methods:

  • Systematic review of published reports on diabetes.
  • Focus on metabolic alterations, treatment strategies, and long-term outcomes.

Main Results:

  • Hemoglobin A1c is the standard for monitoring glycemic control; a 1% decrease lowers diabetes mortality by 21% and myocardial infarction risk by 14%.

Related Experiment Videos

  • Fasting and postprandial glucose levels are critical therapeutic targets, with postprandial hyperglycemia independently increasing cardiovascular disease risk.
  • Intensive glycemic control demonstrably improves management of diabetes-related complications compared to conventional therapy.

    • Conclusions:

    • A comprehensive management approach is essential, acknowledging the intricate metabolic changes in diabetes.
    • Recognizing the complexity of metabolic alterations is key for effective diabetes management.